These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9333262)

  • 41. [New therapeutic strategies. Many of the trails have not yet been validated].
    Delfraissy JF
    Med Mal Infect; 2006 Jul; 36 Suppl 2():S224-30. PubMed ID: 17076001
    [No Abstract]   [Full Text] [Related]  

  • 42. HIV infection.
    Talbot M
    Clin Evid; 2005 Dec; (14):802-17. PubMed ID: 16620438
    [No Abstract]   [Full Text] [Related]  

  • 43. [Antiretroviral therapy 1999/2000].
    Jablonowski H
    Internist (Berl); 1999 Oct; 40(10):1104-18. PubMed ID: 10541640
    [No Abstract]   [Full Text] [Related]  

  • 44. [Synthetic HIV proteinase inhibitors and new prospects for drug therapy of HIV infections and AIDS].
    Galegov GA
    Vopr Virusol; 1997; 42(6):284-6. PubMed ID: 9499245
    [No Abstract]   [Full Text] [Related]  

  • 45. A controlled trial of double versus triple therapy for HIV.
    Feldmesser M; Falkenberg J
    N Engl J Med; 1998 Jan; 338(3):196; author reply 197. PubMed ID: 9441224
    [No Abstract]   [Full Text] [Related]  

  • 46. [What is the correct way to use protease inhibitors?].
    Agosto M
    Sidahora; 1996; ():33-5. PubMed ID: 11364293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New ammunition in the battle against AIDS].
    Agosto M
    Sidahora; 1997; ():25-6. PubMed ID: 11364803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FDA rapidly approves HIV protease inhibitors for children.
    Fox JL
    Nat Biotechnol; 1997 May; 15(5):404. PubMed ID: 9131607
    [No Abstract]   [Full Text] [Related]  

  • 49. A multicentre cohort experience with double-boosted protease inhibitors.
    Stebbing J; Scourfield A; Koh G; Taylor C; Taylor S; Wilkins E; Gazzard B; Nelson M; Jones R
    J Antimicrob Chemother; 2009 Aug; 64(2):434-5. PubMed ID: 19474068
    [No Abstract]   [Full Text] [Related]  

  • 50. Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors.
    Tavel JA; Miller KD; Masur H
    Clin Infect Dis; 1999 Mar; 28(3):643-76. PubMed ID: 10194094
    [No Abstract]   [Full Text] [Related]  

  • 51. HIV infection.
    Talbot M
    Clin Evid; 2006 Jun; (15):937-54. PubMed ID: 16973039
    [No Abstract]   [Full Text] [Related]  

  • 52. Trial in youngest group points to HIV treatment overhaul.
    Dolgin E
    Nat Med; 2011 Apr; 17(4):393. PubMed ID: 21475208
    [No Abstract]   [Full Text] [Related]  

  • 53. Reviving protease inhibitors: new data and more options.
    Murphy RL
    J Acquir Immune Defic Syndr; 2003 Jun; 33 Suppl 1():S43-52; quiz S53, S55-6. PubMed ID: 12946064
    [No Abstract]   [Full Text] [Related]  

  • 54. ABT-378/r helpful in failing patients.
    AIDS Patient Care STDS; 2000 May; 14(5):281-2. PubMed ID: 10833817
    [No Abstract]   [Full Text] [Related]  

  • 55. [Early treatment of sexual exposure to human immunodeficiency virus].
    Derancourt C; Drobacheff C; Verraes S; Beguinot I; Bernard P
    Ann Dermatol Venereol; 2000 Jan; 127(1):122-4. PubMed ID: 10717578
    [No Abstract]   [Full Text] [Related]  

  • 56. CDC guidelines for occupational exposure to HIV.
    Holleran R
    Air Med J; 1998; 17(1):24. PubMed ID: 10176559
    [No Abstract]   [Full Text] [Related]  

  • 57. Fresh data on new anti-HIV drugs presented in Durban.
    Leibovich M
    Posit Living; 2000 Aug; 9(7):16-7. PubMed ID: 12492026
    [No Abstract]   [Full Text] [Related]  

  • 58. Different methods to calculate the inhibitory quotient of boosted single protease inhibitors and their association with virological response.
    Winston A; Patel N; Back D; Khoo S; Bulbeck S; Mandalia S; Pozniak AL; Nelson M; Moyle G; Gazzard B; Boffito M
    J Acquir Immune Defic Syndr; 2006 Apr; 41(5):675-6. PubMed ID: 16652044
    [No Abstract]   [Full Text] [Related]  

  • 59. Analysis of ritonavir for the treatment of HIV disease in children: abstract and commentary.
    Oleske JM; Bagnoud FX
    JAMA; 1998 Jun; 279(22):1831. PubMed ID: 9628719
    [No Abstract]   [Full Text] [Related]  

  • 60. New hope in HIV disease.
    Balter M
    Science; 1996 Dec; 274(5295):1988-9. PubMed ID: 8984652
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.